Wearing-Off Scales in Parkinson's Disease: Critique and Recommendations

被引:89
作者
Antonini, Angelo [1 ]
Martinez-Martin, Pablo [2 ,3 ]
Chaudhuri, Ray K. [4 ,5 ]
Merello, Marcelo [6 ]
Hauser, Robert [7 ]
Katzenschlager, Regina [8 ]
Odin, Per [9 ]
Stacy, Mark [10 ]
Stocchi, Fabrizio [11 ]
Poewe, Werner [12 ]
Rascol, Oliver [13 ]
Sampaio, Cristina [14 ]
Schrag, Anette [15 ]
Stebbins, Glenn T. [16 ]
Goetz, Christopher G. [17 ]
机构
[1] IRCCS San Camillo, Dept Parkinsons Dis & Movement Disorders, Venice, Italy
[2] Carlos III Inst Hlth, Area Appl Epidemiol, Natl Ctr Epidemiol, Madrid, Spain
[3] Carlos III Inst Hlth, CIBERNED, Madrid, Spain
[4] Kings Coll London, Natl Parkinson Fdn Ctr Excellence, London, England
[5] Inst Psychiat, London, England
[6] FLENI, Movement Disorders Sect, Buenos Aires, DF, Argentina
[7] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA
[8] Danube Hosp SMZ Ost, Dept Neurol, Vienna, Austria
[9] Cent Hosp, Dept Neurol, Bremerhaven, Germany
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] IRCCS San Raffaele, Inst Neurol, Rome, Italy
[12] Univ Innsbruck Hosp, Dept Neurol, A-6020 Innsbruck, Austria
[13] Lab Pharmacol Med & Clin, Toulouse, France
[14] Lisbon Sch Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal
[15] UCL, Dept Clin Neurosci, Inst Neurol, London, England
[16] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA
[17] Rush Univ, Med Ctr, Dept Neurol Serv, Chicago, IL 60612 USA
关键词
Parkinson's disease; wearing-off; clinimetrics; psychometrics; rating scales; validity; reliability; DUODENAL LEVODOPA INFUSION; MOTOR FLUCTUATIONS; DOUBLE-BLIND; PATIENT QUESTIONNAIRE; HOME DIARY; VALIDATION; ISTRADEFYLLINE; PROGRESSION; EFFICACY; TOOL;
D O I
10.1002/mds.23875
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Wearing-off occurs in the majority of patients with Parkinson's disease after a few years of dopaminergic therapy. Because a variety of scales have been used to estimate wearing-off, the Movement Disorder Society commissioned a task force to assess their clinimetric properties. A systematic review was conducted to identify wearing-off scales that have either been validated or used in Parkinson's patients. A scale was designated "Recommended" if it had been used in clinical studies beyond the group that developed it, if it had been specifically used in Parkinson's disease reports, and if clinimetric studies had established that it is valid, reliable, and sensitive. "Suggested" scales met 2 of the above criteria, and those meeting 1 were "Listed." We identified 3 diagnostic and 4 severity rating scales for wearing-off quantification. Two questionnaires met the criteria to be Recommended for diagnostic screening (questionnaires for 19 and 9 items), and 1 was Suggested (questionnaire for 32 items). Only the patient diaries were Recommended to assess wearing-off severity, with the caveat of relatively limited knowledge of validity. Among the other severity assessment tools, the Unified Parkinson Disease Rating Scale version 3 and the version revised from the Movement Disorders Society were classified as Suggested, whereas the Treatment Response Scale was Listed. (C) 2011 Movement Disorder Society
引用
收藏
页码:2169 / 2175
页数:7
相关论文
共 39 条
[1]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[2]  
[Anonymous], ARCH NEUROL
[3]  
[Anonymous], MOV DISORD
[4]   Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome [J].
Antonini, Angelo ;
Isaias, Ioannis U. ;
Canesi, Margherita ;
Zibetti, Maurizio ;
Mancini, Francesca ;
Manfredi, Luigi ;
Dal Fante, Marco ;
Lopiano, Leonardo ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2007, 22 (08) :1145-1149
[5]   Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations [J].
Colosimo, Carlo ;
Martinez-Martin, Pablo ;
Fabbrini, Giovanni ;
Hauser, Robert A. ;
Merello, Marcelo ;
Miyasaki, Janis ;
Poewe, Werner ;
Sampaio, Cristina ;
Rascol, Olivier ;
Stebbins, Glenn T. ;
Schrag, Anette ;
Goetz, Christopher G. .
MOVEMENT DISORDERS, 2010, 25 (09) :1131-1142
[6]   Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility-an open-label, 6-week study [J].
Eggert, Karla ;
Skogar, Orjan ;
Amar, Khaled ;
Luotonen, Liisa ;
Kuoppamaki, Mikko ;
Leinonen, Mika ;
Nissinen, Helena ;
Oertel, Wolfgang .
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (03) :333-342
[7]   Does levodopa slow or hasten the rate of progression of Parkinson's disease? [J].
Fahn, S .
JOURNAL OF NEUROLOGY, 2005, 252 (Suppl 4) :37-42
[8]  
Fahn S, 2004, NEW ENGL J MED, V351, P2498
[9]  
Fahn S., RECENT DEV PARKINSON, V2, P153
[10]   Scales to assess psychosis in Parkinson's disease:: Critique and recommendations [J].
Fernandez, Hubert H. ;
Aarsland, Dag ;
Fenelon, Gilles ;
Friedman, Joseph H. ;
Marsh, Laura ;
Troster, Alexander I. ;
Poewe, Werner ;
Rascol, Olivier ;
Sampalo, Cristina ;
Stebbins, Glenn T. ;
Goetz, Christopher G. .
MOVEMENT DISORDERS, 2008, 23 (04) :484-500